ROCK2-IN-17
ROCK2-IN-17 is an orally active and selective ROCK2 inhibitor with an IC50 of 8.1 nM. ROCK2-IN-17 achieves its antifibrotic effect by inhibiting the TGF-β/Smad and ROCK2/STAT3 signaling pathways. ROCK2-IN-17 can be used for pulmonary fibrosis research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C24H18FN9O2
- Masse moléculaire:483.46
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
ROCK2 8.1 nM (IC50) |
STAT3 |
In Vitro
ROCK2-IN-17 (Compound 39) exhibits an IC50 of 1.4 μM against ROCK1, a ROCK1/ROCK2 selectivity index of 200, and demonstrates ROCK2 selectivity in a screen of 81 kinases at a concentration of 1 μM[1].
ROCK2-IN-17 (2.5-10 μM; 48 h) suppresses TGF-β1-induced fibroblast activation in NIH-3T3 and MRC-5 cells[1].
ROCK2-IN-17 (5 μM; 24 h) inhibits TGF-β1-induced NIH-3T3 fibroblast migration in wound healing and transwell migration assays[1].
ROCK2-IN-17 (0-10 μM) dose-dependently reduces p-STAT3, p-Smad2/3 and α-SMA expression in TGF-β1-stimulated NIH-3T3 and MRC-5 fibroblasts, indicating inhibition of the ROCK2/STAT3 and TGF-β/Smad signaling pathways[1].
ROCK2-IN-17 (0.37-30 μM) shows weak inhibitory activity against hERG channels in automated patch-clamp assays, inhibiting them by only 11.4% at a concentration of 30 μM, with an hERG IC50 > 30 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:NIH-3T3
-
Concentration:2.5, 5, 10 μM
-
Incubation Time:48 h
-
Result:Suppressed TGF-β1-induced fibroblast activation in a dose-dependent manner.
Reduced the TGF-β1-induced increase in NIH-3T3 cell viability, indicating antifibrotic activity in fibroblasts.
-
Cell Line:MRC-5
-
Concentration:2.5, 5, 10 μM
-
Incubation Time:48 h
-
Result:Suppressed TGF-β1-induced fibroblast activation in a dose-dependent manner.
Reduced the TGF-β1-induced increase in MRC-5 cell viability, supporting its antifibrotic effect in human lung fibroblasts.
-
Cell Line:NIH-3T3
-
Concentration:5 μM
-
Incubation Time:24 h
-
Result:Reduced TGF-β1-induced wound closure in NIH-3T3 cells.
TGF-β1 increased the wound closure rate from 25.7% to 51.7%, while compound administration effectively attenuated this migration-promoting effect.
Reduced the number of TGF-β1-induced migrating NIH-3T3 cells in the transwell assay, confirming inhibition of fibroblast migration.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male C57BL/6 mice challenged with Bleomycin (4 U/kg) by intratracheal administration on day 1[1]
-
Dosage:50, 100 mg/kg
-
Administration:Oral gavage (p.o.); once daily; for 14 days
-
Result:Attenuated bleomycin-induced pulmonary fibrosis in vivo.
Improved body weight changes and reduced hydroxyproline content in lung homogenates, indicating decreased collagen deposition.
Mitigated alveolar structural distortion, dense extracellular matrix fiber formation, lung parenchymal thickening, collagen deposition and inflammatory cell infiltration according to H&E and Masson staining.
Reduced α-SMA fluorescence intensity in lung tissues according to immunofluorescence staining.
Dose-dependently downregulated the mRNA expression of α-SMA, COL1A1 and fibronectin in lung tissues.
Showed no obvious pathological abnormalities in heart, liver, spleen or kidney sections after 14 days of administration.
Chemical Information
-
Masse moléculaire 483.46
-
Formule C24H18FN9O2
-
SMILES
C[C@@H](C1=NC(C2=CN=C3C=CC(NC4=CC=C5C(C=NN5)=C4)=NN32)=NO1)NC(C6=CC=C(C=C6)F)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- ROCK2-IN-17
- ROCK
- TGF-beta/Smad
- STAT
- ROCK2 inhibitor
- selective
- orally active
- ROCK1 selectivity
- TGF-β/Smad signaling pathway
- ROCK2/STAT3 signaling pathway
- fibroblast activation
- fibroblast migration
- α-SMA
- COL1A1
- fibronectin
- hydroxyproline
- bleomycin-induced pulmonary fibrosis model
- NIH-3T3
- MRC-5
- C57BL/6 mouse
- pulmonary fibrosis
- Inhibitor
- inhibitor
- inhibit